Adheris Health Limited (ASX:AHE)
Australia · Delayed Price · Currency is AUD 0.0130
0.00 (0.00%)
Sep 8, 2026, 12:54 PM AEST
Adheris Health Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 8 | 8 | 51 | 275 | 136 | 65 | |
Market Cap Growth | -71.16% | -84.89% | -81.62% | 102.05% | 110.46% | -42.82% |
Enterprise Value | -1 | -0 | 57 | 265 | 116 | 68 |
Last Close Price | 0.01 | 0.01 | 0.08 | 0.50 | 0.25 | 0.17 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | - | 347.51 | - | - |
Forward PE | - | 6.00 | 29.69 | 135.14 | - | - |
PS Ratio | 0.24 | 0.23 | 0.80 | 2.80 | 1.39 | 0.96 |
PB Ratio | -3.40 | -3.13 | 48.26 | 5.34 | 2.81 | 1.87 |
P/TBV Ratio | - | - | 48.26 | - | - | - |
P/FCF Ratio | - | - | - | 53.74 | - | - |
P/OCF Ratio | - | - | - | 53.06 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | - | - | 0.91 | 2.70 | 1.19 | 1.01 |
EV/EBITDA Ratio | - | - | - | 323.11 | - | - |
EV/FCF Ratio | - | - | - | 51.80 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | -0.05 | -0.05 | 16.59 | 0.24 | 0.27 | 0.39 |
Debt / EBITDA Ratio | - | - | - | 11.10 | - | - |
Debt / FCF Ratio | - | - | - | 2.46 | - | - |
Net Debt / Equity Ratio | 3.85 | 3.85 | 6.76 | -0.06 | -0.02 | 0.17 |
Net Debt / EBITDA Ratio | 0.58 | 0.58 | -0.59 | -3.62 | 0.23 | -0.41 |
Net Debt / FCF Ratio | 0.92 | 0.92 | -0.49 | -0.58 | 0.68 | -10.65 |
Asset Turnover | 1.20 | 1.20 | 0.91 | 1.01 | 1.12 | 0.85 |
Quick Ratio | 0.68 | 0.68 | 0.93 | 0.67 | 0.78 | 0.47 |
Current Ratio | 0.76 | 0.76 | 1.95 | 0.71 | 0.85 | 0.52 |
Return on Equity (ROE) | - | - | -240.60% | -4.67% | -27.24% | -41.94% |
Return on Assets (ROA) | -35.79% | -35.79% | -11.77% | -0.28% | -5.04% | -12.70% |
Return on Capital Employed (ROCE) | 673.90% | 673.90% | -66.60% | -0.80% | -11.20% | -37.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -51.96% | -56.36% | -118.97% | 0.29% | -8.30% | -26.80% |
FCF Yield | -123.81% | -134.30% | -28.39% | 1.86% | -1.20% | -0.85% |
Buyback Yield / Dilution | -15.15% | -12.10% | 5.29% | -9.57% | -44.12% | -19.47% |